Unicycive grants director Manning 27,000 stock options

The restricted stock units vest partly upon grant and monthly over 12 months beginning November 1, 2026, subject to continued service.

Rhea-AI Filing Summary

Unicycive Therapeutics, Inc. director Meredith Manning received grants on October 28, 2026, of 3,350 restricted stock units and 27,000 stock options covering common stock. The restricted stock units are payable solely in common stock; 837 shares vest upon grant and 209 vest monthly over 12 months beginning November 1, 2026, subject to continued service. The options have a $3.76 exercise price, an exercise date of October 28, 2027, and an expiration date of October 28, 2036.

Insider Trade Summary

Grant/Award: 30,350 shares

Grant/Award 2 txns

Insider Manning Meredith

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1	3,350	$0.00	$0.00
Grant/Award	Stock Options	27,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 3,350 contracts (Direct); Stock Options — 27,000 contracts (Direct)

Footnotes (1)

1. F1. Represents grant of restricted stock units payable solely in common stock of the Issuer. 837 shares vest upon grant and 209 vest monthly over 12 months beginning Nov. 1, 2026, subject to the Reporting Person's continued service with the Issuer.

Key Figures

Restricted stock units: 3,350 units Stock options: 27,000 options Exercise price: $3.76 per share +4 more

7 metrics

Restricted stock units 3,350 units Granted October 28, 2026

Stock options 27,000 options Granted October 28, 2026

Exercise price $3.76 per share Stock options

Shares vesting upon grant 837 shares Restricted stock units

Monthly vesting 209 shares monthly over 12 months Beginning November 1, 2026, subject to continued service

Exercise date October 28, 2027 Stock options

Expiration date October 28, 2036 Stock options

Key Terms

Restricted Stock Units, Stock Options, exercise price, vest

4 terms

Restricted Stock Units financial

"grant of restricted stock units payable solely in common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Options financial

"Stock Options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion or exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"837 shares vest upon grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What awards did UNCY director Meredith Manning receive?

On October 28, 2026, Unicycive Therapeutics director Meredith Manning received 3,350 restricted stock units payable solely in common stock and 27,000 stock options covering common stock.

How do Meredith Manning's UNCY restricted stock units vest?

The restricted stock units provide for 837 shares to vest upon grant, followed by 209 shares monthly over 12 months beginning November 1, 2026, subject to Meredith Manning's continued service with Unicycive.

What are the exercise price and dates for Meredith Manning's UNCY stock options?

The 27,000 stock options have a $3.76 exercise price, an exercise date of October 28, 2027, and an expiration date of October 28, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/29/2026 - 04:30 PM EDT Accepted by SEC EDGAR 10/29/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manning Meredith

(Last) (First) (Middle)

C/O UNICYCIVE THERAPEUTICS, INC.

1975 W. EL CAMINO REAL SUITE 204

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	10/28/2026		A		3,350		(1)	(1)	Common Stock	3,350	$0	3,350	D
Stock Options	$3.76	10/28/2026		A		27,000		10/28/2027	10/28/2036	Common Stock	27,000	$0	27,000	D

Explanation of Responses:

1. Represents grant of restricted stock units payable solely in common stock of the Issuer. 837 shares vest upon grant and 209 vest monthly over 12 months beginning Nov. 1, 2026, subject to the Reporting Person's continued service with the Issuer.

	/s/ Meredith Manning	10/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)